Advanced Proteome Therapeutics (TSXV:APC.H) OCF Yield %: -851.94 (As of Jun. 25, 2026)


What is Advanced Proteome Therapeutics OCF Yield %?

Advanced Proteome Therapeutics TSXV:APC.H OCF Yield % is -851.94 as of Jun. 25, 2026.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Advanced Proteome Therapeutics's Trailing 12-Month Cash Flow from Operations is C$-1.76 Mil, and Market Cap is C$0.21 Mil. Therefore, Advanced Proteome Therapeutics's OCF Yield % for today is -851.94%.

The historical rank and industry rank for Advanced Proteome Therapeutics's OCF Yield % or its related term are showing as below:

TSXV:APC.H' s OCF Yield % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -851.94

TSXV:APC.H's OCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -8.55 vs TSXV:APC.H: -851.94

Advanced Proteome Therapeutics's OCF Margin % for the quarter that ended in Apr. 2023 was %.

Advanced Proteome Therapeutics OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Advanced Proteome Therapeutics OCF Yield % Related Terms

Advanced Proteome Therapeutics OCF Yield % Historical Data

* Premium members only.

The historical data trend for Advanced Proteome Therapeutics's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Proteome Therapeutics OCF Yield % Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.03 -29.53 -24.48 -5.17 -15.09

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.22 -19.36 -69.56 -39.39 -622.46

TSXV:APC.H vs VRTX, REGN, SGEN: OCF Yield % Comparison

For the Biotechnology subindustry, Advanced Proteome Therapeutics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Proteome Therapeutics OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's OCF Yield % falls into.


Advanced Proteome Therapeutics OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Advanced Proteome Therapeutics's OCF Yield % for the fiscal year that ended in Jul. 2022 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-0.898 / 5.95155
=-15.09%

Advanced Proteome Therapeutics's annualized OCF Yield % for the quarter that ended in Apr. 2023 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.96 * 4 / 0.616905
=-622.46%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -851.94 mean?
Advanced Proteome Therapeutics (TSXV:APC.H) has a OCF Yield % of -851.94 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Advanced Proteome Therapeutics and its competitors.
Is Advanced Proteome Therapeutics' OCF Yield % too high?
Advanced Proteome Therapeutics' current OCF Yield % is -851.94.
How does Advanced Proteome Therapeutics' OCF Yield % compare to VRTX and REGN?
Advanced Proteome Therapeutics' OCF Yield % of -851.94 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Advanced Proteome Therapeutics and its competitors. Advanced Proteome Therapeutics's current OCF Yield % is -851.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Proteome Therapeutics stock overvalued right now?
Advanced Proteome Therapeutics (TSXV:APC.H) has a current OCF Yield % of -851.94. The current OCF Yield % is -851.94. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Advanced Proteome Therapeutics (TSXV:APC.H), the current OCF Yield % is -851.94 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced Proteome Therapeutics Business Description

Address 104 8337 Eastlake Drive, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.